Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial
Condition: Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Interventions: Drug: ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg); Drug: high-intensity statin monotherapy (atoravastatin 40mg) Sponsor: Yonsei University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angioplasty | Cholesterol | Coronary Angioplasty | Percutaneous Coronary Intervention | Research | Statin Therapy | Vytorin | Zetia